Progenity to Showcase New Data at Digestive Disease Week®

Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, this week announced three upcoming poster presentations.

SAN DIEGO—May 6, 2019–Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, this week announced three upcoming poster presentations.

Alongside their women’s health products, Progenity has an extensive and innovative pipeline of ingestible molecular diagnostics and therapeutic products in development for gastrointestinal disorders, such as inflammatory bowel disease and small intestinal bacterial overgrowth. Progenity will be presenting three posters at Digestive Disease Week® 2019 held May 18–21 in San Diego, California:

Title: Development of a Swallowable Diagnostic Capsule to Monitor Gastrointestinal Health
Presenting Author: Mitchell Jones, M.D., Ph.D., Vice President, Translation and Clinical Development at Progenity
Session: Advanced Imaging of the Upper and Lower GI Tract
Date and Time: May 18, 2019; 12:00 PM – 2:00 PM PST
Poster Number: Sa1717
Location: Poster Hall, San Diego Convention Center

Title: Development of Targeted Therapeutic Antibodies for the Treatment of Inflammatory Bowel Disease
Presenting Author: Mitchell Jones, M.D., Ph.D., Vice President, Translation and Clinical Development at Progenity
Session: IBD – Comparative Effectiveness Studies
Date and Time: May 19, 2019; 12:00 PM – 2:00 PM PST
Poster Number: Su1875
Location: Poster Hall, San Diego Convention Center

Title: A Comparison Study of Systemic Versus Targeted Intracecal Anti-TNF∝ Monoclonal Antibody in an Adoptive T-cell Transfer Murine Model of Colitis
Author: Mitchell Jones, M.D., Ph.D., Vice President, Translation and Clinical Development at Progenity
Session: Animal Models – Preclinical Treatment of Intestinal Inflammation
Date and Time: May 19, 2019; 12:00 PM – 2:00 PM PST
Poster Number: Su1809
Location: Poster Hall, San Diego Convention Center

More information about these studies is available here.

Support